Dr. Patrick Harrington, Ph.D. is a Clinical Microbiology Reviewer at the U.S. Food and Drug Administration, Center Drug Evaluation and Research, Division of Antiviral Products, in Silver Spring, MD. He is a virologist by training, with research experience with RNA viruses and HIV/SIV. He analyzes non-clinical and clinical virology data, reviews study protocols, and provides
Dr. Patrick Harrington, Ph.D. is a Clinical Microbiology Reviewer at the U.S. Food and Drug Administration, Center Drug Evaluation and Research, Division of Antiviral Products, in Silver Spring, MD. He is a virologist by training, with research experience with RNA viruses and HIV/SIV. He analyzes non-clinical and clinical virology data, reviews study protocols, and provides virology-related guidance to sponsors and other FDA scientific disciplines involved in the development of antiviral drugs, biologics and microbicides. Prior to joining FDA in 2008, he was a Research Assistant Professor at the University of North Carolina at Chapel Hill School of Medicine, Department of Microbiology and Immunology, where he also worked closely with investigators in the Carolina Vaccine Institute and Center for AIDS Research. He received his Ph.D. and postdoctoral training at UNC-Chapel Hill, and also has pre-clinical research experience in the biotechnology industry.
